NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)

NEXTURNBIOSCIENCE Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14,377	10,602	13,737	10,644	20,632	52,700
Short-Term Investments	6,013	5,570	2,260	12,425	11,500	-
Trading Asset Securities	19,356	19,690	15,144	5,078	9,051	1,260
Cash & Short-Term Investments	39,746	35,863	31,141	28,147	41,184	53,960
Cash Growth	8.82%	15.16%	10.64%	-31.66%	-23.68%	809.25%
Accounts Receivable	2,259	3,347	6,713	5,963	2,753	3,085
Other Receivables	1,271	1,117	958.61	2,081	1,229	-
Receivables	5,484	8,622	8,701	8,353	4,301	4,788
Inventory	9,492	8,438	6,247	7,023	5,352	6,982
Prepaid Expenses	40.55	67.35	75.47	121.12	51.8	19.25
Other Current Assets	102.05	117.25	612.59	322.12	57.62	1,037
Total Current Assets	54,865	53,107	46,777	43,966	50,946	66,786
Property, Plant & Equipment	27,085	27,227	27,955	28,628	12,662	16,043
Long-Term Investments	64,252	65,722	83,476	42,099	55,221	3,650
Goodwill	1,656	1,656	1,656	1,656	-	-
Other Intangible Assets	925.27	993.89	1,168	2,205	123.23	136.15
Long-Term Accounts Receivable	82,480	82,213	81,191	80,238	-	-
Long-Term Deferred Tax Assets	-	-	-	-	509.21	798.98
Long-Term Deferred Charges	0	0	0	0	0	0
Other Long-Term Assets	1,724	2,081	1,771	1,466	19,487	11,937
Total Assets	233,024	233,037	243,994	200,257	138,949	99,351
Accounts Payable	2,097	2,059	2,882	4,147	946.83	717.07
Accrued Expenses	489.79	377.72	555.68	593.37	236.14	118.81
Short-Term Debt	11,337	16,096	10,846	8,236	25,456	-
Current Portion of Long-Term Debt	-	-	64,375	625	-	-
Current Portion of Leases	810.15	874.01	798.78	803.49	732.96	22.52
Current Income Taxes Payable	388.49	322.47	3,274	8.2	127.62	-
Current Unearned Revenue	45.9	32.62	87.83	42.71	-	40.02
Other Current Liabilities	3,059	3,072	10,854	5,246	15,718	1,170
Total Current Liabilities	18,227	22,833	93,672	19,702	43,218	2,069
Long-Term Debt	68,900	64,000	-	64,375	-	-
Long-Term Leases	134.26	253.39	749.74	1,519	2,186	17.87
Long-Term Deferred Tax Liabilities	3,862	4,058	6,553	2,046	-	-
Other Long-Term Liabilities	5,322	5,269	5,006	3,922	578.85	304.8
Total Liabilities	96,542	96,413	105,981	91,983	46,214	2,583
Common Stock	31,701	30,427	23,509	19,427	16,610	5,923
Additional Paid-In Capital	65,450	65,394	61,033	45,093	35,733	46,494
Retained Earnings	38,241	39,723	53,083	43,821	46,734	51,341
Treasury Stock	-81.25	-81.25	-81.25	-	-6,990	-6,990
Comprehensive Income & Other	1,171	1,161	470	-66.18	646.76	-0
Shareholders' Equity	136,481	136,624	138,014	108,274	92,735	96,768
Total Liabilities & Equity	233,024	233,037	243,994	200,257	138,949	99,351
Total Debt	81,181	81,223	76,769	75,558	28,375	40.39
Net Cash (Debt)	-41,436	-45,361	-45,628	-47,412	12,808	53,920
Net Cash Growth	-	-	-	-	-76.25%	808.57%
Net Cash Per Share	-3551.73	-4149.54	-4523.61	-6984.29	1997.46	8408.77
Filing Date Shares Outstanding	12.67	12.16	9.4	7.77	6.41	6.41
Total Common Shares Outstanding	12.67	12.16	9.4	7.77	6.41	6.41
Working Capital	36,638	30,274	-46,895	24,264	7,728	64,717
Book Value Per Share	10768.80	11231.71	14686.92	13933.75	14462.04	15090.95
Tangible Book Value	133,900	133,974	135,190	104,414	92,612	96,632
Tangible Book Value Per Share	10565.16	11013.90	14386.39	13436.98	14442.82	15069.72
Land	19,143	19,143	19,143	19,143	5,013	9,767
Buildings	7,938	7,938	7,938	8,071	4,426	6,661
Machinery	10,045	9,942	9,625	11,114	5,451	5,497
Construction In Progress	149.67	-	82.5	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.